Corstrata Welcomes Chris Watson as Chief Strategy Officer
SAVANNAH, Ga. (PRWEB) May 01, 2023 -- Corstrata, a leading provider of digital wound and ostomy consultative services, has appointed Chris Watson as its fractional Chief Strategy Officer to lead the company's expansion into new value-based care models for chronic wound and ostomy patients.
With over 20 years of experience in marketing, sales, and strategic leadership, Chris brings extensive knowledge of quickly understanding market dynamics and equipping companies with strategies and tactics that increase market relevance and drive significant revenue growth. In her role as COO and CMO of Brightree, a SaaS-based healthcare IT software company, Chris managed the company's marketing, sales, M&A, and product growth strategies that resulted in significant growth and a successful strategic exit to ResMed.
As the founder and leader of in90group, Watson and her team deliver expertise gained through serving in different sales and marketing leadership roles for companies in multiple industry verticals, with a particular emphasis on healthcare. By delivering actionable blueprints, in90group architects and executes go-to-market strategies and tactics that have proven to build powerful brands and jump-start revenues in record time.
"As we continue to expand our services and grow our national footprint, we are thrilled to have Chris join our team as Chief Strategy Officer," said Katherine Piette, CEO of Corstrata. "Her deep domain expertise in healthcare IT and technology-enabled services companies, coupled with her proven track record of driving significant revenue growth, make her an invaluable addition to our leadership team. We look forward to working with her to take Corstrata to the next level as we continue to develop national value-based customer contracts."
Corstrata transforms chronic wound and ostomy care delivery by combining algorithmic treatment protocols with access to scarce nurse experts. With a team of certified nurses licensed in all 50 states and a robust, data-driven telehealth solution, Corstrata enables payers and providers to optimize care, reduce complications, and lower the overall cost of care. Recent data shows Corstrata's services improve patient healing outcomes by 30% and reduce costs by 40%, with a 99 NPS patient score.
Watson added, "I am thrilled to join Corstrata as fractional chief strategy officer at this exciting time in the company's history. As the healthcare industry more consistently embraces virtual care services and technology, I believe Corstrata is uniquely positioned to address one of the biggest challenges facing our nation – access to high-quality, specialized care. When you combine Corstrata's proven virtual wound and ostomy care model with today's healthcare workforce challenges, you find a powerful combination that I believe is poised to deliver tremendous value for patients, payers, and providers."
For more information about Corstrata's value-based wound and ostomy services, please visit http://www.corstrata.com or contact the team at [email protected]
About Corstrata
Corstrata is a virtual care solution that utilizes technology to provide access to scarce certified wound and ostomy nurses at the patient's bedside in post-acute provider settings, including home health, hospice, skilled nursing facilities, and emerging hospital-at-home providers. Corstrata's team of WOC nurses provides consultations with provider staff at the patient's bedside, either through HIPAA-compliant video or through review of store-and-forward wound images, to improve clinical and financial outcomes for providers.
Katherine Piette, Corstrata, https://www.corstrata.com/, 1 912-999-7033, [email protected]
Share this article